Annual Working Capital
$239.39 M
+$20.76 M+9.50%
December 31, 2023
Summary
- As of February 22, 2025, ATXS annual working capital is $239.39 million, with the most recent change of +$20.76 million (+9.50%) on December 31, 2023.
- During the last 3 years, ATXS annual working capital has risen by +$199.46 million (+499.45%).
- ATXS annual working capital is now at all-time high.
Performance
ATXS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$336.14 M
-$5.38 M-1.58%
September 30, 2024
Summary
- As of February 22, 2025, ATXS quarterly working capital is $336.14 million, with the most recent change of -$5.38 million (-1.58%) on September 30, 2024.
- Over the past year, ATXS quarterly working capital has increased by +$154.06 million (+84.61%).
- ATXS quarterly working capital is now -7.51% below its all-time high of $363.45 million, reached on March 31, 2024.
Performance
ATXS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ATXS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.5% | +84.6% |
| 3 y3 years | +499.4% | +84.6% |
| 5 y5 years | +589.0% | +84.6% |
ATXS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.4% | -7.5% | +240.9% |
| 5 y | 5-year | at high | +605.6% | -7.5% | +890.8% |
| alltime | all time | at high | +2119.1% | -7.5% | +3015.9% |
Astria Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $336.14 M(-1.6%) |
| Jun 2024 | - | $341.52 M(-6.0%) |
| Mar 2024 | - | $363.45 M(+51.8%) |
| Dec 2023 | $239.39 M(+9.5%) | $239.39 M(+31.5%) |
| Sep 2023 | - | $182.08 M(-8.0%) |
| Jun 2023 | - | $197.82 M(-5.2%) |
| Mar 2023 | - | $208.77 M(-4.5%) |
| Dec 2022 | $218.63 M(+79.4%) | $218.63 M(+95.1%) |
| Sep 2022 | - | $112.04 M(+13.6%) |
| Jun 2022 | - | $98.60 M(-9.8%) |
| Mar 2022 | - | $109.25 M(-10.4%) |
| Dec 2021 | $121.87 M(+205.2%) | $121.87 M(-6.1%) |
| Sep 2021 | - | $129.82 M(-4.6%) |
| Jun 2021 | - | $136.06 M(-5.0%) |
| Mar 2021 | - | $143.28 M(+258.8%) |
| Dec 2020 | $39.94 M(+17.7%) | $39.94 M(-17.7%) |
| Sep 2020 | - | $48.53 M(-3.1%) |
| Jun 2020 | - | $50.09 M(-4.7%) |
| Mar 2020 | - | $52.55 M(+54.9%) |
| Dec 2019 | $33.93 M | $33.93 M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $37.16 M(-11.1%) |
| Jun 2019 | - | $41.82 M(-13.5%) |
| Mar 2019 | - | $48.35 M(+39.2%) |
| Dec 2018 | $34.74 M(+203.5%) | $34.74 M(-14.0%) |
| Sep 2018 | - | $40.42 M(-11.6%) |
| Jun 2018 | - | $45.72 M(+261.7%) |
| Mar 2018 | - | $12.64 M(+10.4%) |
| Dec 2017 | $11.45 M(-63.3%) | $11.45 M(-25.0%) |
| Sep 2017 | - | $15.25 M(-31.1%) |
| Jun 2017 | - | $22.13 M(-12.6%) |
| Mar 2017 | - | $25.32 M(-18.9%) |
| Dec 2016 | $31.20 M(-44.1%) | $31.20 M(-21.5%) |
| Sep 2016 | - | $39.76 M(+9.5%) |
| Jun 2016 | - | $36.31 M(-21.0%) |
| Mar 2016 | - | $45.95 M(-17.6%) |
| Dec 2015 | $55.77 M(+417.0%) | $55.77 M(-15.4%) |
| Sep 2015 | - | $65.89 M(-11.8%) |
| Jun 2015 | - | $74.68 M(+276.0%) |
| Mar 2015 | - | $19.86 M(+84.1%) |
| Dec 2014 | $10.79 M(-61.0%) | $10.79 M |
| Dec 2013 | $27.65 M | - |
FAQ
- What is Astria Therapeutics annual working capital?
- What is the all time high annual working capital for Astria Therapeutics?
- What is Astria Therapeutics annual working capital year-on-year change?
- What is Astria Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Astria Therapeutics?
- What is Astria Therapeutics quarterly working capital year-on-year change?
What is Astria Therapeutics annual working capital?
The current annual working capital of ATXS is $239.39 M
What is the all time high annual working capital for Astria Therapeutics?
Astria Therapeutics all-time high annual working capital is $239.39 M
What is Astria Therapeutics annual working capital year-on-year change?
Over the past year, ATXS annual working capital has changed by +$20.76 M (+9.50%)
What is Astria Therapeutics quarterly working capital?
The current quarterly working capital of ATXS is $336.14 M
What is the all time high quarterly working capital for Astria Therapeutics?
Astria Therapeutics all-time high quarterly working capital is $363.45 M
What is Astria Therapeutics quarterly working capital year-on-year change?
Over the past year, ATXS quarterly working capital has changed by +$154.06 M (+84.61%)